Challenges in developing Digital Health

According to Facts and Factors market research report, the Worldwide Digital Health Market size & share revenue is expected to grow from USD 84.08 Billion in 2019 to reach USD 220.94 Billion by 2026, at 14.8% annual CAGR growth during forecast period of 2021-2026.

From mobile medical applications and tools that assist clinical evaluations doctors make every day to machine learning and artificial intelligence, emerging technology has driven a revolution in health care. Digital health platforms have a lot of promise in terms of enhancing our efforts to accurately detect and manage illness, as well as enhancing consumer health care delivery. Digital innovations are providing doctors with a more holistic view of patient well-being through data access, while also allowing patients more control over their health. Although rising effectiveness, digital health has the ability to enhance patient outcomes

In this panel discussion we want to address the key challenges that the Digital Health industry faces today, by asking our speakers questions such as:

• What is the digital readiness of countries to adapt digital health technologies?
• What is the value perception of digital technologies by different stakeholders?
• How should the procurement model of digital health technologies differ from therapeutics or MedTech?

The panel will be composed of the following speakers:

Nicholas James Rumble (CEO, Curaizon)

• Chief Executive Officer (CEO) of Curaizon, company that aims to revolutionizing healthcare and improving drug-adherence through big data analytics delivered via the blockchain.

Niels Christian Ganderup (Senior Investment Manager – HealthTech & Data, Copenhagen Capacity)

• Scientist by training, he is currently the leading expert on developing and implementing business opportunities in Greater Copenhagen. He helps to support foreign companies, investors and talent in identifying and capitalizing on business opportunities, form initial considerations to final establishment. He is main area of expertise is Pharma, Biotech and Healthtech.

Eske Kvanner Aasvang (Founder & CRDO, Ward 24/7)

• Chief physician from the Department of Anesthesia and Surgery at the Center for Cancer and Organ Diseases at Rigshospitalet.He investigates and aims to understand why the complications occur with surgery in patients.
• In his research Eske uses innovative health technology such as artificial intelligence and computer algorithms. He is working on a system that makes it possible to intervene if the patient's condition worsens, thus reducing the risk of serious complications, enabling constant monitoring in wards.